Denis A. Lacombe

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 02, 2026

Patterns of endpoint use in oncology pragmatic clinical trials: A review of randomised studies.

Patterns of endpoint use in oncology pragmatic clinical trials: A review of randomised studies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 20, 2026

Academic clinical cancer trials to improve patient outcomes.

Academic clinical cancer trials to improve patient outcomes.

Journal: The Lancet. Oncology

Published: April 01, 2026

European Organisation for Research and Treatment of Cancer (EORTC) 2025 Program for Early Career Investigators: Advancing Ideas into Clinical Research.

European Organisation for Research and Treatment of Cancer (EORTC) 2025 Program for Early Career Investigators: Advancing Ideas into Clinical Research.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 13, 2026

Empowering the next generation of clinical cancer researchers: Structure, activities, and vision of the European Organisation for Research and Treatment of Cancer (EORTC) Young and Early Career Investigator (Y-ECI) network.

Empowering the next generation of clinical cancer researchers: Structure, activities, and vision of the European Organisation for Research and Treatment of Cancer (EORTC) Young and Early Career Investigator (Y-ECI) network.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 13, 2026

Reduce bureaucracy in clinical trials now.

Reduce bureaucracy in clinical trials now.

Journal: Nature medicine

Published: January 06, 2026

Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the EORTC-ESTRO radiotherapy infrastructure for Europe (E2-RADIatE) project.

Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the EORTC-ESTRO radiotherapy infrastructure for Europe (E2-RADIatE) project.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 22, 2025

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 20, 2025

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Journal: JAMA oncology

Published: December 18, 2025

Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.

Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.

Journal: Journal of cancer policy

Published: September 13, 2025

Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study.

Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 02, 2025

How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

Journal: Cancer treatment reviews

Published: June 13, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026